From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cancer is a complex disease that involves a sequence of gene-environment interactions in a progressive process that cannot occur without dysfunction in multiple systems, including DNA repair, apoptotic and immune functions. Epigenetic mechanisms, responding to numerous internal and external cues in a dynamic ongoing exchange, play a key role in mediating environmental influences on gene expression and tumor development. HYPOTHESIS: The hypothesis put forth in this paper addresses the limited success of treatment outcomes in clinical oncology. It states that improvement in treatment efficacy requires a new paradigm that focuses on reversing systemic dysfunction and tailoring treatments to specific stages in the process. It requires moving from a reductionist framework of seeking to destroy aberrant cells and pathways to a transdisciplinary systems biology approach aimed at reversing multiple levels of dysfunction. CONCLUSION: Because there are many biological pathways and multiple epigenetic influences working simultaneously in the expression of cancer phenotypes, studying individual components in isolation does not allow an adequate understanding of phenotypic expression. A systems biology approach using new modeling techniques and nonlinear mathematics is needed to investigate gene-environment interactions and improve treatment efficacy. A broader array of study designs will also be required, including prospective molecular epidemiology, immune competent animal models and in vitro/in vivo translational research that more accurately reflects the complex process of tumor initiation and progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Early-warning signals for critical transitions
Scheffer, M., Bascompte, J., Brock, W. A., Brovkin, V., Carpenter, S. R., Dakos, V., Held, H., van Nes, E. H., Rietkerk, M., & Sugihara, G. (2009) · Nature · doi:10.1038/nature08227 · Cited by 4,854 · cited 2×
“A recent review of these nonlinear transitions [16] described a condition of ‘critical slowing down’ that seems to be generic across systems.”
BackgroundJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“The methylation of histones [ 55 ] and histone acetylation can be modified by shortchain fatty acids, such as butyrate.”
BackgroundEnvironmental epigenomics and disease susceptibility
Jirtle, R. L., & Skinner, M. K. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2045 · Cited by 2,492 · cited 5×
“Loss of imprinting (LOI) of IGF2 is common in lung cancer [11,65].”
BackgroundInfluentialHoeijmakers, J. H. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804615 · Cited by 2,239 · cited 1×
“This shifts the paradigm from one that targets the killing of renegade cancer cells [24], to one that focuses on reversing the complex interactions involved in systemic dysregulation [25], Cell behavior (e.”
BackgroundABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
Tse, C., Shoemaker, A. R., Adickes, J., Anderson, M. G., Chen, J., Jin, S., Johnson, E. F., Marsh, K. C., Mitten, M. J., Nimmer, P., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5836 · Cited by 1,992
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“P53, which involves complex signaling pathways central to tumor development, responds to a broad range of signals that determine whether the cellular response will be DNA repair, cell metabolism, autophagy, apoptosis or cell cycle arrest [3, 4 ].”
BackgroundPhenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · cited 2×
“Importantly, it has been demonstrated that epigenetic change precedes cancer and confers risk for cancer [65].”
Background
Cited by
The environment ontology: contextualising biological and biomedical entities
Buttigieg, P., Morrison, N., Smith, B., Mungall, C. J., Lewis, S. E., & the ENVO Consortium (2013) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-4-43 · Cited by 358
Integrated Multi-Omics Analyses in Oncology: A Review of Machine Learning Methods and Tools
Nicora, G., Vitali, F., Dagliati, A., Geifman, N., & Bellazzi, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01030 · Cited by 284
“While complexities underling cancer still hampers our understanding of how this disease arises and progresses (8), multi-omics approaches have been suggested as promising tools to dissect patient’s dysfunctions in multiple biological systems that may be altered by cancer mechanisms (9).”
BackgroundOvercoming Barriers in Cancer Biology Research: Current Limitations and Solutions
(2025) · doi:10.3390/cancers17132102 · Cited by 44
Dynamic visualization of multi-level molecular data: The Director package in R
Icay, K., Liu, C., & Hautaniemi, S. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2017.10.013 · Cited by 8
Metadata
- Authors
- Knox, S. S.
- Venue
- Cancer Cell International
- Published
- 2010
- Volume
- 10
- Issue
- 1
- Pages
- 11
- ISSN
- 1475-2867 (ISSN-L)
- OpenAlex
- W2135255500
- Cited by
- 115
- References
- 13
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer. https://app.cochat.ai/papers/10.1186/1475-2867-10-11
- The paper
- Knox, S. S. (2010). From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancer. Cancer Cell International. https://doi.org/10.1186/1475-2867-10-11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.